Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T22:22:12.907Z.
Calculation as of: 2026-10-06T22:22:12.907Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4b900084dfad819c514917b73a3910c9d2e92354b8183d11bfa5ab73513aed11
PE RATIO
N/A
SeaStar Medical Holding Corporation
Market Cap
$9.05M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.82M
PE Ratio
N/A
TTM Avg
38.25
3Y Avg
38.25
5Y Avg
38.25
Market Cap
$9.83M
PE Ratio
N/A
TTM Avg
3.33
3Y Avg
3.33
5Y Avg
3.33
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SeaStar Medical Holding Corporation (ICU) | $9.05M | N/A | N/A | N/A | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.10M | N/A | N/A | N/A | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $8.82M | N/A | 38.25 | 38.25 | 38.25 |
| Ainos, Inc. (AIMD)vs › | $9.50M | N/A | N/A | N/A | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $9.71M | N/A | N/A | N/A | N/A |
| MetaVia Inc. (MTVA)vs › | $9.75M | N/A | N/A | N/A | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.33M | N/A | N/A | N/A | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.83M | N/A | 3.33 | 3.33 | 3.33 |
| Valion Bio, Inc. (VBIO)vs › | $9.86M | N/A | N/A | N/A | N/A |
| HeartSciences Inc. (HSCS)vs › | $8.14M | N/A | N/A | N/A | N/A |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$3.19
Forward EPS (Est.)
$-3.66
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
